This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Lead Chemical Company, Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: **Innovator Yuji Matsuya: Pioneering Neurodegenerative Disease Research**
Introduction
Yuji Matsuya, an inventive mind based in Imizu, Japan, has made significant strides in the field of neurodegenerative disease research. With a keen focus on developing effective treatments, Matsuya has secured a patent that holds promise for future medical applications.
Latest Patents
Matsuya's notable patent, titled "Compound having neurite-outgrowing activity," introduces a novel compound that shows potential in the prevention or treatment of neurodegenerative diseases. This innovative compound is characterized by a specific formula where components X, Y, and Z enable its therapeutic properties. It offers a new avenue for medical and veterinary applications by promoting neurite outgrowth, crucial for neural regeneration.
Career Highlights
Currently, Matsuya is affiliated with Lead Chemical Company, Limited, where he continues to contribute to advancements in chemical and pharmaceutical research. His work emphasizes the importance of understanding and addressing the cellular mechanisms associated with neurodegenerative disorders.
Collaborations
Throughout his career, Matsuya has collaborated with various professionals, including his coworker, Hideo Nemoto. These collaborations enhance the innovative potential of their projects and accelerate the progress in developing new therapeutic solutions.
Conclusion
In summary, Yuji Matsuya's contributions to the field of neurodegenerative disease treatments through his patented compound signify his commitment to improving human health. His ongoing work at Lead Chemical Company, Limited, alongside dedicated colleagues, positions him as a notable inventor in the landscape of medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile